Ambrx Biopharma Inc. Increase Decrease In Operating Lease Liability
Ambrx Biopharma Inc. reported Increase Decrease In Operating Lease Liability of -$1.40 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2023-08-09
- Ambrx Biopharma Inc. increase decrease in operating lease liability for the quarter ending 2023-06-30 was -$673.00K.
- Ambrx Biopharma Inc. increase decrease in operating lease liability for the quarter ending 2023-03-31 was -$731.00K.
- Ambrx Biopharma Inc. increase decrease in operating lease liability for the quarter ending 2022-06-30 was -$206.00K.
- Ambrx Biopharma Inc. increase decrease in operating lease liability for the quarter ending 2022-03-31 was -$597.00K.
- Ambrx Biopharma Inc. increase decrease in operating lease liability for fiscal 2022 was -$2.11M.
- Ambrx Biopharma Inc. increase decrease in operating lease liability for fiscal 2021 was -$1.74M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|
| 2023-06-30 | -$673.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.40M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$731.00K 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | -$2.11M 10-K · filed 2023-03-30 | ||
| 2022-06-30 | -$206.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$803.00K 10-Q · filed 2023-08-09 | |
| 2022-03-31 | -$597.00K 10-Q · filed 2023-05-11 | ||
| 2021-12-31 | -$1.74M 10-K · filed 2023-03-30 | ||
| 2021-06-30 | -$869.00K 6-K · filed 2022-08-29 | ||
| 2020-12-31 | -$1.69M 20-F · filed 2022-04-26 | ||
| 2019-12-31 | -$1.64M 20-F · filed 2022-04-26 |